Share of Cost, New research leads to FDA approval of first drug to treat radiation sickness

Tuesday, Sep. 15th 2015 6:00 AM

New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.

Posted on Tuesday, Sep. 15th 2015 6:00 AM | by Share of Cost | in Share of Cost | Comments Off on Share of Cost, New research leads to FDA approval of first drug to treat radiation sickness